These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22233302)

  • 41. Daily Symptom Variability in Patients With Stable COPD: A Narrative Review.
    Wu M; Wang Z; Li M; Li K
    West J Nurs Res; 2018 Oct; 40(10):1543-1561. PubMed ID: 28459177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between patient perception of the ability to perform morning activities and findings on clinical examination in COPD patients in Romania.
    Mihălţan F; Ungureanu D
    Pneumologia; 2016; 65(3):138-41. PubMed ID: 29542886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physical activity in COPD patients decreases short-acting bronchodilator use and the number of exacerbations.
    Katajisto M; Koskela J; Lindqvist A; Kilpeläinen M; Laitinen T
    Respir Med; 2015 Oct; 109(10):1320-5. PubMed ID: 26298024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life.
    Rossi A; Zanardi E; Poletti V; Cazzola M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1383-92. PubMed ID: 26229457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical and integrated management of COPD.
    Bettoncelli G; Blasi F; Brusasco V; Centanni S; Corrado A; De Benedetto F; De Michele F; Di Maria GU; Donner CF; Falcone F; Mereu C; Nardini S; Pasqua F; Polverino M; Rossi A; Sanguinetti CM
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 May; 31 Suppl 1():3-21. PubMed ID: 24820963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinants of different dimensions of disease severity in asthma and COPD : pulmonary function and health-related quality of life.
    Wijnhoven HA; Kriegsman DM; Hesselink AE; Penninx BW; de Haan M
    Chest; 2001 Apr; 119(4):1034-42. PubMed ID: 11296166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Patient-reported parameters in chronic obstructive pulmonary disease].
    Moya V; Nieto D; Marín JM
    Arch Bronconeumol; 2010; 46 Suppl 8():15-9. PubMed ID: 21334551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.
    Jochmann A; Scherr A; Jochmann DC; Miedinger D; Török SS; Chhajed PN; Tamm M; Leuppi JD
    Swiss Med Wkly; 2012; 142():w13567. PubMed ID: 22481636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
    Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Rousseau R;
    BMC Pulm Med; 2006 Feb; 6():3. PubMed ID: 16460562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain.
    Soler-Cataluña JJ; Sauleda J; Valdés L; Marín P; Agüero R; Pérez M; Miravitlles M
    Arch Bronconeumol; 2016 Jun; 52(6):308-15. PubMed ID: 26774700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
    Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions.
    Weldam SW; Lammers JW; Heijmans MJ; Schuurmans MJ
    BMC Fam Pract; 2014 Aug; 15():140. PubMed ID: 25087008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of chronic obstructive pulmonary disease.
    Chandy D; Aronow WS
    Compr Ther; 2006; 32(4):230-5. PubMed ID: 17898428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degree of control of patients with chronic obstructive pulmonary disease in Spain: SINCON study.
    Baloira A; Gonzalez-Moro JMR; Sanjuán E; Trigueros JA; Casamor R
    BMC Pulm Med; 2018 Dec; 18(1):183. PubMed ID: 30509238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient's perception of symptoms related to morning activity in chronic obstructive pulmonary disease: the SYMBOL Study.
    Kim YJ; Lee BK; Jung CY; Jeon YJ; Hyun DS; Kim KC; Yu SK; Choi HS; Shin WH; Lee KH
    Korean J Intern Med; 2012 Dec; 27(4):426-35. PubMed ID: 23269884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
    Szmidt M
    Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.